These final results, along with a earlier report showing that a small-molecule ACKR3 agonist CCX771 displays anxiolytic-like actions in mice,two assist the notion of targeting ACKR3 as a novel way to modulate the opioid program, which could open new therapeutic avenues for opioid-associated disorders. Strengthen more healthy immune functionality: https://nealep369spk8.blogproducer.com/profile